This table shows the survey response data for the IIEF questionnaire, which is a scientifically validated instrument. The table is quite large. If you want to study the data more in detail, you can download it by pressing on the down arrow symbol at the bottom of the chart.
The reference values are as follows:
At the time of writing this post, our results before the drug are somewhat better than the controls in the referenced study. This may be because on average, our cases are likely younger than the typical erectile dysfunction patient (would need to check the full text of the study). In any case, what these results definitely put to rest, is that PFS patients may have been suffering from sexual dysfunction before taking the drug, an argument that naysayers and some doctors have been using for years.
Source:
The following chart shows that, once again, all three main drug categories are causing a similar level of sexual dysfunction (results post drug):
Comparing overall figures with results from study cited below shows the following:
- Survey participants closely match controls except for desire (see age related comment earlier). This validates our data, i.e. makes it difficult to brush off.
- Our data shows a clear worsening between on drug and off drug for all involved drugs. This post-drug worsening is a unique characteristic of our syndrome and gives credence to the hypothesis that they are linked.
- The study participant are less severely affected in the erectile dysfunction and orgasmic function domain than the participants in the Rosen paper (see below).
- Our study participants are more severely affected in the desire and satisfaction domains than the Rosen participants.
A claim in the medical world is that depression is a strong predisposing factor for PFS. Hence, in the following chart we’re comparing post-drug IIEF scores (males only) for patients which have received a diagnosis of depression vs, those who have not.
Our data only negligibly support this claim. PFS patients with a pre-existing diagnosis of depression seem to do only slightly worse on the IIEF questionnaire post-drug than those without a medical history of depression. The effect is a little more pronounced for PSSD patients.
You may need to mouse over the charts to see the details of the values as the charting software we are using is a little buggy.